Volume 16 - Issue 11 - November, 2004
Insights
Commentary
08/01/2008
Nitin Barman, MD, John H. Chiu, MD, Stephen G. Ellis, MD
Nitin Barman, MD, John H. Chiu, MD, S...
Retrograde cannulation of a peripheral artery is a necessary step for current percutaneous coronary procedures. Since the first reported case of coronary angiography via the radial artery by Campeau in 1989, the transradial approach has been...
Retrograde cannulation of a peripheral artery is a necessary step for current percutaneous coronary procedures. Since the first reported case of coronary angiography via the radial artery by Campeau in 1989, the transradial approach has been...
Retrograde cannulation of a...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
*Gian B. Danzi, MD, *Cinzia Capuano, MD, *Marco Sesana, MD, *Roberto Baglini, MD, §Antonio L. Bartorelli, MD, §Daniela Trabattoni, MD, †Angela Migliorini, MD, †David Antoniucci, MD
*Gian B. Danzi, MD, *Cinzia Capuano, ...
The Tecnic Carbostent™ (Sorin Biomedica, Saluggia, Italy) is a balloon-expandable, stainless steel tubular coronary stent with a unique cellular design and proprietary Carbofilm™ permanent coating.1-3 Recently the stent has been pre-mounted...
The Tecnic Carbostent™ (Sorin Biomedica, Saluggia, Italy) is a balloon-expandable, stainless steel tubular coronary stent with a unique cellular design and proprietary Carbofilm™ permanent coating.1-3 Recently the stent has been pre-mounted...
The Tecnic Carbostent™ (Sorin...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ramazan Akdemir, MD, Hakan Ozhan, MD, Enver Erbilen, MD, Mehmet Yazici, MD, Sinan Albayrak, MD, Huseyin Gunduz, MD, Cihangir Uyan, MD
Ramazan Akdemir, MD, Hakan Ozhan, MD,...
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Efthymios N. Deliargyris, MD, Bharathi Upadhya, MD, Robert J. Applegate, MD, Michael A. Kutcher, MD, Sanjay K Gandhi, MD, David C. Sane, MD
Efthymios N. Deliargyris, MD, Bharath...
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical...
08/01/2008
Journal of Invasive Cardiology
